ArticleJournal of pharmacy & bioallied sciences2024
Intraoperative Diagnosis: Imprint Cytology and Frozen Section in Ovarian Tumor, Averting Additional Surgery.
Article in Journal of pharmacy & bioallied sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A granulosa cell tumor (GCT) is a type of ovarian cancer that constitutes approximately 10% of all ovarian malignancies. In this case, a female patient with hypothyroidism and a history of irregular periods was diagnosed with polycystic ovarian disease (PCOD) after a radiological examination, which subsequently recommended surgery. Frozen section analysis and imprint cytology assisted in the intraoperative diagnosis of the tumor. These diagnostic tools helped adopt a minimally invasive surgery where only the affected ovary was removed, thus avoiding an extra surgical procedure. It is usually described as a low-grade cancer, but it can recur many years later. Therefore, repeated imaging and tumor markers should be used to monitor the patient after the treatment and ensure early detection of the relapse, thus improving the patient's prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.